Results of our recent survey on the stigma of migraine have found that only 6% of people living with migraine…
Continue ReadingPress Release: Migraine Awareness Month is not ‘AstroTurf’
Today in the House of Representatives, Health Minister Greg Hunt accused Eli Lilly of running an ‘AstroTurf’ campaign because they…
Continue ReadingTriptans available without prescription from February 2021
The TGA has recently announced that they will allow two types of triptans to be available from pharmacies from February…
Continue ReadingWelcome to Migraine Awareness Month!
June is Migraine Awareness Month and we are just so excited! There’s a lot going on. Most of the activity…
Continue ReadingPress release: Migraine Awareness Month calls on politicians to make migraine a priority
Australia is joining the world migraine community for the first time in celebrating Migraine Awareness Month throughout June. Patient advocacy…
Continue ReadingWe’re looking for 151 faces of migraine
Tell your story and become a face of migraine.
Continue ReadingPBAC decision on Ajovy deferred
PBAC has decided to defer their decision on Ajovy, but it’s not a ‘no’.
Continue ReadingAimovig, Emgality and Ajovy are all now available on private script
All three CGRP antagonist monoclonal antibodies, Aimovig, Emgality and Ajovy, are all now available with a private prescription.
Continue ReadingStarting to make some noise
Let’s start getting heard.
Continue ReadingDisappointed but we get it: Aimovig pulls out of PBS process
Migraine Australia responds to Novartis’ decision to walk away from the PBS process.
Continue Reading